Prescription opioid use has increased significantly over the past 25 years due to a number of factors including efforts to help patients struggling to cope with pain, overprescribing by providers and marketing by pharmaceutical companies. However, opioids provide euphoria as well as analgesia. 1 This euphoria coupled with iatrogenic physical dependence and addictive qualities has contributed to an epidemic of opioid abuse, addiction and overdose. 2 The increased use of opioids for treating non-cancer chronic pain and the increased use of higher-dose and higher bioavailability formulations has added to what the Centers for Disease Control and the Department of Health and Human Services have referred to as an'epidemic'. 1 Clinicians struggle to weigh the potential benefits of long-term opioids therapy (i.e., use of legitimately obtained prescribed opioids at least five days per week for 90 days) with the risk of misuse or addiction. 3 Recently, the Centers for Disease Control (CDC) has issued prescribing guidelines to address the issue of opioid over-use. 4 Obesity and Chronic Pain Co-Morbidity Patients with severe obesity are more likely to experience chronic pain and related increased functional and psychosocial complications related to chronic pain conditions. 5 Chronic pain also has quality of life implications in patients with severe obesity and has been the subject of a prior review A large-scale survey of over 1 million US residents demonstrated a linear relationship between Body Mass Index (BMI) and chronic pain prevalence. 6 Compared to individuals with normal BMIs, individuals who were overweight reported 20% greater rates of chronic pain, people with Class I obesity reported 68% greater, those with Class II reported 136% greater, and those with clinically severe Class III obesity reported 254% greater rates of chronic pain. 7 Recent research has indicated that although pain ratings and overall medication use is significantly reduced following bariatric surgeries, opioid use not only continues but